Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer
Eman M.E. Dokla, Amal Kamal Abdel‐Aziz, Sandra N. Milik, Amr H. Mahmoud, Mona Kamal Saadeldin, Martin J. McPhillie, Saverio Minucci, Khaled A. M. Abouzid
Topics & Concepts
Aurora B kinaseAurora inhibitorChemistryClonogenic assayKinaseCell cycleCell cycle checkpointCancer researchApoptosisCancer cellPharmacophoreCancerCellBiochemistryCytokinesisBiologyCell divisionGeneticsMicrotubule and mitosis dynamicsCancer-related Molecular PathwaysProtein Degradation and Inhibitors